Patterns of relapse following radiotherapy for differentiated thyroid cancer: Implication for target volume delineation

Radiotherapy and Oncology

Volumn 89, Issue 1, 2008, Pages 105-113

  Azrif, Muhammad ^a   Slevin, Nicholas J ^a   Sykes, Andrew J ^a   Swindell, Ric ^a   Yap, Beng K ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Pattern of relapse; Postoperative margin; Radiotherapy; Target volume; Thyroid cancer

Indexed keywords

IODINE 131;

ADJUVANT THERAPY; ADULT; ARTICLE; BIOPSY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE; SURVIVAL TIME; THYROID CANCER; THYROIDECTOMY; TIME SERIES ANALYSIS;

COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PROGNOSIS; SURVIVAL RATE; THYROID NEOPLASMS;

EID: 53049091830     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.05.023     Document Type: Article

References (30)

1. British Thyroid Association. Guidelines for the management of thyroid cancer. 2nd ed.; 2007.
2. Pacini F., Schlumberger M., Ellisei R., Smit J.W.A., and Wiersinga W. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. E J Endocrinol 154 (2006) 787-803
3. Tubiana M. External radiotherapy and radioiodine in the treatment of thyroid cancer. World J Surg 5 (1981) 75-81
4. Wu X.L., Yu H.H., Li Q.H., et al. Value of postoperative radiotherapy for thyroid cancer. Head Neck Surg 10 (1987) 107-112
5. Simpson W.J., Panzarella T., Carruthers J.S., et al. Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys 14 (1988) 1063-1075
6. Benker G., Olbricht T., Reinwein D., et al. Survival rates in patients with differentiated thyroid carcinoma: influence of postoperative external radiotherapy. Cancer 65 (1990) 1517-1520
7. Philips P., Hanzen C., Andry G., et al. Postoperative irradiation for thyroid cancer. Eur J Surg Oncol 19 (1993) 399-404
8. Esik O., Nemeth G., and Eller J. Prophylactic external irradiation in differentiated thyroid cancer: a retrospective study over a 30-year observation period. Oncology 51 (1994) 372-379
9. O'Connell M.E.A., A'Hern R.P., and Harmer C.L. Results of external beam radiotherapy in differentiated thyroid carcinoma: a retrospective study from the Royal Marsden hospital. Eur J Cancer 30 (1994) 733-739
10. Farahati J., Reiners C., Stuschke M., et al. Differentiated thyroid cancer: impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration. Cancer 77 (1996) 172-180
11. Tsang R.W., Brierley J.D., Simpson W.J., et al. The effects of surgery, radioiodine and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer 82 (1998) 375-388
12. Eichhorn W., Tabler H., Lippold R., Lochmann M., Schreckenberger M., and Bartenstein P. Prognostic factors determining long term survival in well differentiated thyroid cancer: an analysis of four hundred eighty four patients undergoing therapy and aftercare at the same institution. Thyroid 13 (2003) 949-958
13. Brierley J., Tsang R., Panzarella T., and Bana N. Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years. Clin Endocrinol 63 (2005) 418-427
14. Robbins K.T., Medina J.E., and Wolfe G.T. Standardizing neck dissection terminology: official report of the Academy's committee for the head and neck surgery and oncology. Arch Otolaryngol Head Neck Surg 117 (1991) 601
15. Chow S.M., Law S.C.K., Mendenhall W.M., Au S.K., Chan P.T.M., Leung T.W., et al. Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy. Int J Rad Oncol Biol Phys 52 (2002) 784-795
16. Kim T.H., Yang D.S., Jung K.Y., Kim C.Y., and Choi M.S. Value of external irradiation for locally advanced papillary thyroid cancer. Int J Rad Oncol Biol Phys 55 (2003) 1006-1012
17. Grant C.S., Hay I.D., Gough I.R., Bergstralh E.J., Goellner J.R., and McConahey W.M. Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important?. Surgery 104 (1988) 954-962
18. Ford D., Giridharan S., McConkey C., Hartley A., Brammer C., Watkinson J.C., et al. External beam radiotherapy in the management of differentiated thyroid cancer. Clin Oncol 15 (2003) 337-341
19. Bremner D.J., and Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 43 (1999) 1095-1101
20. Fowler J., Chappell R., and Ritter M. Is for prostate tumours really low?. Int J Radiat Oncol Biol Phys 50 (2001) 1021-1031
21. Gowda R.V., Henk J.M., Mais K.L., Sykes A.J., Swindell R., and Slevin N.J. Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden hospital experience. Rad Oncol 68 (2003) 105-111
22. Sykes A.J., Burt P.A., Slevin N.J., Stout R., and Marrs J.E. Radical radiotherapy for carcinoma of the oesophagus: an effective alternative to surgery. Rad Oncol 48 (1998) 15-21
23. Cowan R.A., McBain C.A., Ryder W.D., Wylie J.P., Logue J.P., Turner S.L., et al. Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy. Int J Rad Oncol Biol Phys 59 (2004) 197-207
24. Livsey J.E., Cowan R.A., Wylie J.P., Swindell R., Read G., Khoo V.S., et al. Hypofractionated conformal radiotherapy in carcinoma of the prostate: five year outcome analysis. Int J Radiat Oncol Biol Phys 57 (2003) 1254-1259
25. Dralle H., Damm I., Scheumann G.F.W., Kotzerke J., Kupsch E., Geerlings H., et al. Compartment orientated microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today 24 (1994) 112
26. Harmer C., Bidmead M., Shepherd S., et al. Radiotherapy planning techniques for thyroid cancer. Br J Radiol 71 (1998) 1069-1075
27. Ito Y., and Miyauchi A. Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks. World J Surg 31 (2007) 905-915
28. Machens A., Hinze R., Thomusch O., and Dralle H. Patterns of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 26 (2002) 22-28
29. O'Connell M.E., Flower M.A., Hinton P.J., Harmer C.L., and McCready V.R. Radiation dose assessment in radioactive iodine therapy. Dose response relationship in differentiated thyroid carcinoma using quantitative scanning and PET. Radiother Oncol 28 (1993) 16-26
30. Nutting C.M., Convery D.J., Cosgrove V.P., Rowbottom C., Vini L., Harmer C., et al. Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland. Radiother Oncol 60 (2001) 173-180